Aurora D’AMato

Aurora D’AMato

Auto-generated profile, based on publicly available information

Aurora D’AMato

University of Wisconsin, Global Health Institute, Madison WI

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2026 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
MPMayra Betancourt Ponce
Mayra Betancourt Ponce
AHAlexa R. Heaton
Alexa R. Heaton
SBSamantha K. Burkard
Samantha K. Burkard
ADAurora D’AMato
Aurora D’AMato
NBNicha Boonpattrawong
Nicha Boonpattrawong
LBLisa Barroilhet
Lisa Barroilhet

26 October 2025 in bioRxiv
Verified
Preprint
Open access
AHAlexa R. Heaton
Alexa R. Heaton
NBNathaniel J. Burkard
Nathaniel J. Burkard
AGAnqi Gao
Anqi Gao
AHAnna Hoefges
Anna Hoefges
AFArika S. Feils
Arika S. Feils
MSMelissa Skala
Melissa Skala
Immunotherapy has potential for impactful cancer cures by empowering patients’ own immune cells. We developed a radio-immunotherapy regimen that can cure large immunologically hot and cold murine tumors. Here, we explored the divergent role of CD8 T cells during this radio-immunotherapy in contrasting hot colon carcinoma versus cold melanoma. We introduced an immunocompetent mouse model with mCherry-expressing CD8 T cells to provide cell tracking in vivo . We investigated single-cell function, metabolism, and gene expression temporal changes using flow cytometry, in vivo multiphoton imaging, single-cell RNA sequencing, and multiplexed immunofluorescence to determine the underlying mechanisms. We found that in contrast to the hot colon carcinoma model, CD8 T cells from the cold melanoma model do not drive tumor cures, despite getting activated, possibly due to a static oxidative metabolism and exhausted phenotype plus down regulation of tumor MHC-I expression. These findings have implications for improving immunotherapy response in immunologically cold cancers.